Gene · 3568
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma. | Hemasphere | 2023 | 37359190 | PubTator, text mining | PubMed |
| Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses. | Cell Rep | 2023 | 37355988 | PubTator, text mining | PubMed |
| Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST). | JMIR Res Protoc | 2023 | 37351918 | PubTator, text mining | PubMed |
| Pregnancy-associated systemic gene expression compared to a pre-pregnancy baseline, among healthy women with term pregnancies. | Front Immunol | 2023 | 37342349 | PubTator, text mining | PubMed |
| Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial. | Lancet Gastroenterol Hepatol | 2023 | 37336228 | PubTator, text mining | PubMed |
| Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTY. | J Asthma Allergy | 2023 | 37334017 | PubTator, text mining | PubMed |
| Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils. | Front Immunol | 2023 | 37325657 | PubTator, text mining | PubMed |
| The role of the respiratory microbiome in asthma. | Front Allergy | 2023 | 37324782 | PubTator, text mining | PubMed |
| Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities. | Drugs Aging | 2023 | 37316689 | PubTator, text mining | PubMed |
| Finding the Right Biological: Eosinophil Subset Differences in Asthma and Chronic Obstructive Pulmonary Disease. | Am J Respir Crit Care Med | 2023 | 37311240 | PubTator, text mining | PubMed |
| Switching Biological Therapies in Severe Asthma. | Int J Mol Sci | 2023 | 37298514 | PubTator, text mining | PubMed |
| The Multifunctional Protein Syntenin-1: Regulator of Exosome Biogenesis, Cellular Function, and Tumor Progression. | Int J Mol Sci | 2023 | 37298370 | PubTator, text mining | PubMed |
| Biological Treatment for Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: Preliminary Real-World Results from a Tertiary Medical Center. | J Clin Med | 2023 | 37297865 | PubTator, text mining | PubMed |
| Real-World Effectiveness of IL-5/5Ra Targeted Biologics in Severe Eosinophilic Asthma With Comorbid Bronchiectasis. | J Allergy Clin Immunol Pract | 2023 | 37295671 | PubTator, text mining | PubMed |
| Insights into the epigenetics of chronic rhinosinusitis with and without nasal polyps: a systematic review. | Front Allergy | 2023 | 37284022 | PubTator, text mining | PubMed |
| The role of regulatory T cells and follicular T helper cells in HBV infection. | Front Immunol | 2023 | 37275865 | PubTator, text mining | PubMed |
| ACDC: a general approach for detecting phenotype or exposure associated co-expression. | Front Med (Lausanne) | 2023 | 37275375 | PubTator, text mining | PubMed |
| The multidisciplinary approach to eosinophilia. | Front Oncol | 2023 | 37274287 | PubTator, text mining | PubMed |
| Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. | Front Neurol | 2023 | 37273690 | PubTator, text mining | PubMed |
| Management of eosinophil-associated inflammatory diseases: the importance of a multidisciplinary approach. | Front Immunol | 2023 | 37266434 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3568/papers?page=19